Efficacy and safety of Bufei Huoxue capsules in the treatment of stable COPD: A multicenter, double-blind, placebo-controlled, randomized clinical trial
Introduction: Chronic obstructive pulmonary disease (COPD) is a chronic inflammatory condition characterized by irreversible airflow limitation, resulting in significant morbidity and mortality. Bufei Huoxue capsules (BFHX) have demonstrated potential benefits in small-scale clinical studies, includ...
Saved in:
Main Authors: | Yuqin Chen, Bihua Zhong, Zhiwan Wang, Lei Xu, Zhe Cheng, Wenjun He, Jingjing Qi, Yinji Xu, Xiaoying Huang, Li Li, Minfang Li, Yingyun Fu, Peifang Zhang, Weike Li, Huijie Wang, Qian Jiang, Junzhen Gao, Tianci Jiang, Lingling Dai, Yan Cai, Dan Yao, Xuemei Zhong, Wenju Lu, Jiyuan Chen, Donghua Lou, Jiajun Huang, Nanshan Zhong, Chunli Liu, Jian Wang |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2025-09-01
|
Series: | Pharmacological Research - Modern Chinese Medicine |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2667142525000764 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A Subgroup Reanalysis of the Efficacy of Bufei Huoxue Capsules in Patients With “Long‐Covid‐19”
by: Chi Hou, et al.
Published: (2025-04-01) -
The Inhibitory Effect of the Active Ingredients in the Bushen Huoxue Formula on the IL-17A Signaling Pathway and Its Alleviating Effect on Osteoarthritis
by: Wang X, et al.
Published: (2025-05-01) -
Mechanism of Shenyuan Yiqi Huoxue capsule alleviating coronary microvascular dysfunction: network analysis and experimental evidence
by: Jiaping Chen, et al.
Published: (2025-08-01) -
Cardioprotective effect of Yiqi Huoxue decoction on post-myocardial infarction injury mediated by Ca2+ flux through MAMs
by: Yufei Li, et al.
Published: (2025-07-01) -
Effective-Component Compatibility of Bufei Yishen Formula III Protects Lung Air-Blood Barrier by Regulating the Oxidative Stress: via the Nuclear Factor-E2-Related Factor 2 Pathway
by: Xu K, et al.
Published: (2025-07-01)